# Alkermes plc (ALKS): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Alkermes plc (ALKS) is 58/100, ranked against 24,000+ stocks in 35 markets (Quality 68, Value 26, Momentum 58, each scored against its sector).

- StockRank: 58/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 68, Value 26, Momentum 58: each a 0-100 percentile within the stock's sector.
- Position: #11,435 overall, #1,077 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 40.26 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 5.9M.
- Buybacks, last 180 days: the company bought back USD 27.7M on 1 day.

Source: https://moatmap.ai/stock/ALKS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker